- Maturity of the generic drug market in Japan. Increased public skepticism of generic drug quality and supply stability. Repeated NHI drug price revisions. Rising raw material and energy costs. Sluggish allergy market due to lower-than-anticipated pollen.
- Ensuring stable supplies of generic drugs.
- Competition among pharmaceutical companies.
Nippon Chemiphar Co., Ltd.
Greenhouse gas emissions & sustainability report data
In its 2023-04 to 2024-03 reporting, Nippon Chemiphar Co., Ltd. disclosed greenhouse gas emissions of 12.6K t-CO2. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
12.6K t-CO2
2023-04 to 2024-03
Water Usage
152.4K m3
2023-04 to 2024-03
Waste
459 tons
2023-04 to 2024-03
Energy Use
259.5K GJ
2023-04 to 2024-03
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2023-04 to 2024-03 | 12.6K t-CO2 |
| 2021-04 to 2022-03 | 11.5K t-CO2e/year |
| 2019-04 to 2020-03 | 11.8K tCO2e |
| 2014-04 to 2015-03 | 7.1K t-CO2e/year |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- Reduced CO2 emissions by 4.2% year-on-year in FY2023. Reduced general waste by 1.9% year-on-year in FY2023. Reduced industrial waste by 9.1% year-on-year in FY2023. Reduced raw materials by 12.6% year-on-year in FY2023. Reduced packaging materials by 12.1% year-on-year in FY2023.
🎯 Climate & Sustainability Targets
🔜 Short-term
- Achieve sales of 2,000 units of DropScreen by FY2025.
📅 Medium-term
- Sell 14 products in five countries by FY2026.
🌱 ESG Focus Areas
EnvironmentSocialGovernance